Zobrazeno 1 - 10
of 41
pro vyhledávání: '"ACE2-Fc"'
Autor:
Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Ester Lopez, Klasina Chappin, Li-Jin Chan, Francesca L. Mordant, Wen Shi Lee, Nicholas A. Gherardin, Sheila K. Patel, Gemma E. Hartley, Phillip Pymm, James P. Cooney, James G. Beeson, Dale I. Godfrey, Louise M. Burrell, Menno C. van Zelm, Adam K. Wheatley, Amy W. Chung, Wai-Hong Tham, Kanta Subbarao, Stephen J. Kent, P. Mark Hogarth
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/140fea88883d408989768880a06ffb83
Autor:
Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Ester Lopez, Klasina Chappin, Li-Jin Chan, Francesca L. Mordant, Wen Shi Lee, Nicholas A. Gherardin, Sheila K. Patel, Gemma E. Hartley, Phillip Pymm, James P. Cooney, James G. Beeson, Dale I. Godfrey, Louise M. Burrell, Menno C. van Zelm, Adam K. Wheatley, Amy W. Chung, Wai-Hong Tham, Kanta Subbarao, Stephen J. Kent, P. Mark Hogarth
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Joining a function-enhanced Fc-portion of human IgG to the SARS-CoV-2 entry receptor ACE2 produces an antiviral decoy with strain transcending virus neutralizing activity. SARS-CoV-2 neutralization and Fc-effector functions of ACE2-Fc decoy proteins,
Externí odkaz:
https://doaj.org/article/3a2991630f9b42fdb65b29d07a0e335f
Autor:
Kuo‐Yen Huang, Ming‐Shiu Lin, Ting‐Chun Kuo, Ci‐Ling Chen, Chung‐Chih Lin, Yu‐Chi Chou, Tai‐Ling Chao, Yu‐Hao Pang, Han‐Chieh Kao, Rih‐Sheng Huang, Steven Lin, Sui‐Yuan Chang, Pan‐Chyr Yang
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 1, Pp 1-19 (2020)
Abstract To circumvent the devastating pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, a humanized decoy antibody (ACE2‐Fc fusion protein) was designed to target the interaction between viral spike pro
Externí odkaz:
https://doaj.org/article/fe030031a04a43a49c6198793d078d2e
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
The establishment of SARS CoV-2 spike-pseudotyped lentiviral (LV) systems has enabled the rapid identification of entry inhibitors and neutralizing agents, alongside allowing for the study of this emerging pathogen in BSL-2 level facilities. While su
Externí odkaz:
https://doaj.org/article/ae75452bf77c4b16bf88089a9366b31f
Autor:
Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Phongthon Kanjanasirirat, Priyo Budi Purwono, Kaewta Rattanapisit, Balamurugan Shanmugaraj, Duncan R. Smith, Suparerk Borwornpinyo, Arunee Thitithanyanont, Waranyoo Phoolcharoen
Publikováno v:
Frontiers in Plant Science, Vol 11 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease (COVID-19) which has recently emerged as a potential threat to global public health. SARS-CoV-2 is the third known human coronavirus that has h
Externí odkaz:
https://doaj.org/article/69a8c794cad748abbfb0d6305a2bc61e
Autor:
Sai Priya Anand, Yaozong Chen, Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, Cameron F. Abrams, Marzena Pazgier, Andrés Finzi
Publikováno v:
Viruses, Vol 12, Iss 10, p 1104 (2020)
Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is responsible for the current global coronavirus disease 2019 (COVID-19) pandemic, infecting millions of people and causing hundreds of thousands of deaths. The viral entry of SARS-CoV-2 depends
Externí odkaz:
https://doaj.org/article/f80a5aa159eb4c208968ce4068b9d393
Autor:
Alexander Kinna, Rajeev Karattil, Zulaikha Akbar, Giada Mattiuzzo, Vania Baldan, James Sillibourne, Mathieu Ferrari, Yasuhiro Takeuchi, Christopher D.C. Allen, Katarzyna Ward, Katarina Lamb, Martin Pule, Shimobi Onuoha, Reyisa Bughda, Leila Mekkaoui, Emma M. Bentley, Philip Wu, F. Tudor Ilca, Farhaan Parekh, Preeta Datta
Publikováno v:
Journal of Virology
The human angiotensin-converting enzyme 2 acts as the host cell receptor for SARS-CoV-2 and the other members of the Coronaviridae family SARS-CoV-1 and HCoV-NL63. Here, we report the biophysical properties of the SARS-CoV-2 spike variants D614G, B.1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c04af08f3b7537dc264e8a926d82d11
https://doi.org/10.1128/jvi.00685-21
https://doi.org/10.1128/jvi.00685-21
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology
The establishment of SARS CoV-2 spike-pseudotyped lentiviral (LV) systems has enabled the rapid identification of entry inhibitors and neutralizing agents, alongside allowing for the study of this emerging pathogen in BSL-2 level facilities. While su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33fb8342168b5f75806ad8700e712edb
https://doi.org/10.3389/fcimb.2021.663688
https://doi.org/10.3389/fcimb.2021.663688
Autor:
Yahya Asemani, Mahsa Sanaei, Mozhdeh Namvarpour, Mohammad Reza Mohammadi, Reyhaneh Eftekhari, Maryam Bayat
Publikováno v:
International Immunopharmacology
Graphical abstract
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was deployed all around the world. To date, despit
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was deployed all around the world. To date, despit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd237e4fd9cdd2e5ad96ea991b6d4512
http://europepmc.org/articles/PMC7908848
http://europepmc.org/articles/PMC7908848
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.